Ha habido 50 transacciones internas recientes registradas para KalVista Pharmaceuticals, Inc. (KALV), incluyendo 10 compras y 40 ventas. El total de compras internas fue valorado en RSU Award y el total de ventas internas en $1.33M.
Internos destacados con actividad reciente incluyen Venrock Healthcare Capital Partners Iii, L.p., Palleiko Benjamin L, Yea Christopher. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — KALV
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-26 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
Venta Informativa |
3,183 |
$19.12 |
$60.86K |
5,089,354 |
| 2026-03-25 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
Venta Informativa |
160 |
$17.53 |
$2.8K |
5,129,340 |
| 2026-03-09 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
6,693 |
$16.08 |
$107.63K |
451,815 |
| 2026-03-06 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
15,625 |
- |
- |
125,001 |
| 2026-02-23 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
10,034 |
$15.57 |
$156.2K |
442,883 |
| 2026-02-23 |
Yea Christopher |
Chief Development Officer |
Venta Informativa |
4,347 |
$15.57 |
$67.67K |
226,701 |
| 2026-02-23 |
Piekos Brian |
Chief Financial Officer |
Venta Informativa |
1,767 |
$15.57 |
$27.51K |
13,762 |
| 2026-02-23 |
Sweeny Nicole |
Chief Commercial Officer |
Venta Informativa |
3,975 |
$15.57 |
$61.88K |
47,003 |
| 2026-02-23 |
Audhya Paul K. |
Chief Medical Officer |
Venta Informativa |
5,354 |
$15.57 |
$83.34K |
138,983 |
| 2026-02-22 |
Yea Christopher |
Chief Development Officer |
Ejercicio de Opciones (Venta) |
3,125 |
- |
- |
28,125 |
| 2026-02-22 |
Sweeny Nicole |
Chief Commercial Officer |
Ejercicio de Opciones (Venta) |
5,000 |
- |
- |
45,000 |
| 2026-02-22 |
Audhya Paul K. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
5,000 |
- |
- |
45,000 |
| 2026-02-21 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
23,250 |
- |
- |
279,000 |
| 2026-02-21 |
Yea Christopher |
Chief Development Officer |
Ejercicio de Opciones (Venta) |
3,750 |
- |
- |
45,000 |
| 2026-02-21 |
Piekos Brian |
Chief Financial Officer |
Ejercicio de Opciones |
5,000 |
- |
- |
15,529 |
| 2026-02-21 |
Sweeny Nicole |
Chief Commercial Officer |
Ejercicio de Opciones |
6,250 |
- |
- |
45,978 |
| 2026-02-21 |
Audhya Paul K. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
6,250 |
- |
- |
75,000 |
| 2026-02-18 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
1,038 |
$15.00 |
$15.57K |
429,667 |
| 2026-02-18 |
Yea Christopher |
Chief Development Officer |
Venta Informativa |
1,109 |
$15.00 |
$16.64K |
224,173 |
| 2026-02-18 |
Audhya Paul K. |
Chief Medical Officer |
Venta Informativa |
1,163 |
$15.00 |
$17.45K |
133,087 |
| 2026-02-17 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
2,419 |
- |
- |
2,419 |
| 2026-02-17 |
Yea Christopher |
Chief Development Officer |
Ejercicio de Opciones (Venta) |
1,774 |
- |
- |
1,774 |
| 2026-02-17 |
Audhya Paul K. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
2,419 |
- |
- |
2,419 |
| 2026-02-12 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
3,354 |
$15.70 |
$52.66K |
428,286 |
| 2026-02-11 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
7,120 |
- |
- |
99,680 |
| 2026-01-16 |
Palleiko Benjamin L |
Chief Executive Officer |
Concesión de RSU |
325,000 |
- |
- |
325,000 |
| 2026-01-16 |
Piekos Brian |
Chief Financial Officer |
Concesión de RSU |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Sweeny Nicole |
Chief Commercial Officer |
Concesión de RSU |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Audhya Paul K. |
Chief Medical Officer |
Concesión de RSU |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Arif Bilal |
Chief Operations Officer |
Concesión de RSU |
49,000 |
- |
- |
49,000 |
| 2025-12-08 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
7,294 |
$16.51 |
$120.42K |
424,520 |
| 2025-12-06 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
15,625 |
- |
- |
140,626 |
| 2025-11-24 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
10,940 |
$13.45 |
$147.15K |
416,189 |
| 2025-11-24 |
Yea Christopher |
Chief Development Officer |
Venta Informativa |
4,331 |
$13.45 |
$58.26K |
223,508 |
| 2025-11-24 |
Piekos Brian |
Chief Financial Officer |
Venta Informativa |
4,471 |
$13.45 |
$60.14K |
10,529 |
| 2025-11-24 |
Audhya Paul K. |
Chief Medical Officer |
Venta Informativa |
5,296 |
$13.45 |
$71.24K |
131,831 |
| 2025-11-24 |
Sweeny Nicole |
Chief Commercial Officer |
Venta Informativa |
3,813 |
$13.45 |
$51.29K |
39,728 |
| 2025-11-22 |
Yea Christopher |
Chief Development Officer |
Ejercicio de Opciones (Venta) |
3,125 |
- |
- |
31,250 |
| 2025-11-22 |
Audhya Paul K. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
5,000 |
- |
- |
50,000 |
| 2025-11-22 |
Sweeny Nicole |
Chief Commercial Officer |
Ejercicio de Opciones |
5,000 |
- |
- |
43,541 |
| 2025-11-21 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
23,250 |
- |
- |
302,250 |
| 2025-11-21 |
Yea Christopher |
Chief Development Officer |
Ejercicio de Opciones (Venta) |
3,750 |
- |
- |
48,750 |
| 2025-11-21 |
Piekos Brian |
Chief Financial Officer |
Ejercicio de Opciones |
15,000 |
- |
- |
15,000 |
| 2025-11-21 |
Audhya Paul K. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
6,250 |
- |
- |
81,250 |
| 2025-11-21 |
Sweeny Nicole |
Chief Commercial Officer |
Ejercicio de Opciones |
6,250 |
- |
- |
38,541 |
| 2025-11-20 |
Yea Christopher |
Chief Development Officer |
Ejercicio de Opciones (Venta) |
87,390 |
$0.00 |
$375.78 |
- |
| 2025-11-18 |
Palleiko Benjamin L |
Chief Executive Officer |
Venta Informativa |
4,466 |
$14.48 |
$64.67K |
403,879 |
| 2025-11-18 |
Yea Christopher |
Chief Development Officer |
Venta Informativa |
2,683 |
$14.48 |
$38.85K |
133,574 |
| 2025-11-18 |
Audhya Paul K. |
Chief Medical Officer |
Venta Informativa |
3,075 |
$14.48 |
$44.52K |
125,877 |
| 2025-11-17 |
Palleiko Benjamin L |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
6,945 |
- |
- |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
